Athersys Inc (ATHXQ)
0.0049
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
Athersys Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | -0.418 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.0096 |
| September 30, 2015 | 0.0122 |
| June 30, 2015 | 0.0087 |
| March 31, 2015 | 0.0097 |
| December 31, 2014 | 0.0088 |
| September 30, 2014 | 0.0067 |
| June 30, 2014 | 0.0058 |
| March 31, 2014 | 0.006 |
| December 31, 2013 | 0.0089 |
| September 30, 2013 | 0.0151 |
| June 30, 2013 | 0.0146 |
| March 31, 2013 | 0.0132 |
| December 31, 2012 | 0.0083 |
| September 30, 2012 | 0.0262 |
| June 30, 2012 | 0.0111 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.418
Minimum
Jun 2023
--
Maximum
Jun 2019
-0.0246
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.8478 |
| MEI Pharma Inc | -- |
| ContraFect Corp | -- |
| Bristol-Myers Squibb Co | 3.376 |
| Predictive Technology Group Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.428M |
| Total Liabilities (Quarterly) | 43.82M |
| Shareholders Equity (Quarterly) | -36.40M |